Further explorations of surveillance data

Slides:



Advertisements
Similar presentations
M. Samarkos TUBERCULOSIS IN GREECE. INTRODUCTION.
Advertisements

TB and poverty agenda in WPR WHO/WPRO Stop TB. World Health Organization Percentage of population living below US$1 a day.
Overview of current case and treatment outcome definitions Malgosia Grzemska TB Operations and Coordination Stop TB Department Consultation Impact of WHO-endorsed.
Module 9 Part A: Monitoring and Evaluation *Image courtesy of: World Lung Foundation.
Dr R.Reesaul Chest Physician Chest Clinic P. D`or Hospital
Monitoring and Evaluation: A Review of Terms. Goals To provide better treatment for people with tuberculosis in Country X To achieve a treatment success.
World Tuberculosis Day 2014 The TB situation in 2012: Findings from the joint TB surveillance and monitoring report by ECDC and the WHO Regional Office.
Status of Revised National Tuberculosis Control Program (RNTCP) in India Dr Jitendra.
Tuberculosis in the UK 2013 report
1 Global and Regional Tuberculosis (TB) update ACSM workshop, Amman, Jordan April 13-17, 2008 Dr. Sevil Huseynova.
Health Information System “ Consumers’ perspective” Gunnar Bjune March 2014
Outcomes among patients treated for tuberculosis in Limpopo Province, South Africa, Mmakgotso Pilane, Lazarus Kuonza, Eric Maimela.
Monitoring and Evaluation Module 12 – March 2010.
DOTS Expansion: Monitoring Drugs Leopold Blanc TBS, Stop TB WHO, Communicable Diseases.
NATIONAL TB 2012 INDICATOR ANALYSIS REPORT Presented by: Sandile Ginindza Lugogo Sun Hotel 05 th -7 th June 2013 Ministry of Health NTCP.
Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.
Recent Epidemiologic Situations of TB in Myanmar -Preliminary Review of Data from routine TB surveillance focusing on Case Finding- 9 May 2014, Nay Pyi.
Public Health. TB-DOTS program Government commitment Case detection by DSSM among symptomatic patients self-reporting to health services Standard short-course.
Indicators in Malaria Program Phases By Bayo S Fatunmbi [Technical Officer, Monitoring & Evaluation] ERAR-GMS, WHO Cambodia & Dr. Michael Lynch Epidemiologist.
Indicators in Malaria Program Phases By Bayo S Fatunmbi [Technical Officer, Monitoring & Evaluation] ERAR-GMS, WHO Cambodia.
Surveillance, Epidemiology, and Outbreak Investigations Branch Division of Tuberculosis Elimination Centers for Disease Control and Prevention (CDC) Epidemiology.
Understanding the impact of disease control: TB epidemiology and the GFATM.
Dr Ral Antic Chair Scientific Committee IUATLD-APR Australia Pre-Conference Workshop 1 National TB Control Program Summary & Remarks.
World Tuberculosis Day 2016 Monitoring the implementation of the Framework Action Plan to Fight Tuberculosis in the European Union – Situation in 2014.
Instructional Objectives:
TB/ HIV CONTROL AND MANAGEMENT IN SOUTH AFRICA
TUBERCULOSIS IN JAPAN ANNUAL REPORT – 2016.
TB- HIV Collaborative activities in Romania- may 2006 status
World Tuberculosis Day 2014
Philippe Glaziou Geneva, 12 October 2009
World Tuberculosis Day 2013
2007 Jordan Population and Family Health Survey
PROGRESS IN GLOBAL TB CONTROL
The burden of TB in the Western Pacific
Nino Mdivani NTP of Georgia
World Tuberculosis Day 2016
World Tuberculosis Day 2014
TUBERCULOSIS SURVEILLENCE KENYA
Dr. Joseph Bana-Koiri Dr. Gilbert Hiawalyer Papua New Guinea
Tuberculosis in Wales Annual Report 2018 Data to the end of 2017
SURVEILLANCE AND EPIDEMIOLOGY OF TUBERCULOSIS IN FIJI
TB epidemiological situation in Kyrgyzstan
WS on Surveillance & Epidemiology
Expected effects of adopting a 9 month regimen for multidrug-resistant tuberculosis: a population modelling analysis  Dr Emily A Kendall, MD, Anthony.
Four indirect measures of TB incidence
Success and failure in TB surveillance in Hungary
Direct estimates of the burden of disease EURO Workshop November 2003
From TB control to integrated respiratory disease control
Review of Wednesday 5th May
DOTS IMPACT TO TUBERCULOSIS IN LITHUANIA
Cheng shiming National TB Center in China May,3, 2004
TB in South Africa.
Surveys of TB infection and disease
National Tuberculosis Control Program in Vietnam
Four indirect measures of TB incidence
TB epidemiology in Bulgaria
Epidemiology of Tuberculosis in Hong Kong
PROGRESS IN GLOBAL TB CONTROL
Country Presentation on Analysis of Korea
Huang Fei National center for TB control and prevention, China
THE GLOBAL EPIDEMIOLOGY OF TUBERCULOSIS WORLD HEALTH ORGANIZATION
TB SUREVEILLANCE MEETING: OBJECTIVES
TB notification in Hong Kong
Four indirect measures of TB incidence
Further explorations of surveillance data
Surveillance, Monitoring and Evaluation Working Group
Further explorations of surveillance data
Tuberculosis in Wales Annual Report 2017 Data to the end of 2016
Global DOTS Expansion: will we reach the Targets?
Webinar Priority IPC Indicators
Presentation transcript:

Further explorations of surveillance data Cross-checking estimates of TB incidence (EMR) Identifying districts with poor diagnosis (Syria) Exploring diagnostic accuracy (Jordan) Explaining variation in treatment outcomes (S. Africa) Strengthening evidence for trends in TB incidence (Morocco) Strengthening evidence for DOTS impact (Peru) Understanding the limits of DOTS impact (China)

Standards and norms in TB epidemiology: 2 approaches 1. Comparisons with known standards e.g. ss+ inc = 50 * ARTI (Styblo) ss+/pulmonary cases = 70% EP/all TB = 15-20% 2. Anomalies, deviations, and inconsistencies: incidence inversely related to average age regional variation in sex ratio provincial differences in suspects/cases See indicator list

Evaluating case detection and treatment outcomes

Smear-positive diagnosis by province, Syria 1.0 0.9 0.8 0.7 0.6 ss+/all pulmonary 0.5 0.4 0.3 0.2 0.1 0.0 A Ar D H I K L M OS Q R RD S SW T Z

TB suspects by province: Jordan 7000 6000 5000 4000 Suspects/100,000 population 3000 2000 1000 IRBID SALT ZARKA MA'AN KARAK AQAUBA AMMAN MAFRAQ TAFILAH MADABA

Compliance with treatment, Hlabisa, South Africa 1 0.9 Probability of remaing on treatment 0.8 Clinic 0.7 Volunteer CHW 0.6 15 30 45 60 75 90 105 120 135 150 165 180 Days

Compliance with short-course chemotherapy 1 0.9 proportion remaining compliant 0.8 0.7 0.6 0.5 1 2 3 4 5 6 months Yougelson & Joubert, SAMJ 1991

Evaluating the impact of TB control

Changing aetiology of tuberculosis Netherlands model, 45-49 yr-olds 160 140 120 progressive primary 100 exogenous reinfection Incidence rate/100K/year 80 endogenous reactivation 60 40 20 1950 1953 1956 1959 1962 1965 1968 1971 1974

Reward for diagnostic effort: Peru 0.04 0.03 0.02 rate/increase in smear exam rate Increase in notification 0.01 -0.01 92-93 93-94 94-95 95-96 96-97 97-98 98-99 Years compared

Source of retreatment patients Changshou County, China 70 60 n = 288 50 40 percentage 30 20 10 out of county in county, out in project project